Showing results (111-120 of 171) with videos related to
Sort By:
Pageof 18
Lung Cancer (Amsterdam, Netherlands)|May 4, 2023
Spatial profiling of the microenvironment reveals low intratumoral heterogeneity and STK11-associated immune evasion in therapy-naïve lung adenocarcinomasHannah Goldschmid, Klaus Kluck, Markus Ball, et al.Oncoimmunology|February 1, 2021
A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinomaJan Budczies, Martina Kirchner, Klaus Kluck, et al.JTO Clinical and Research Reports|April 13, 2026
Treatment Patterns, Outcome, and Quality of Life of Patients With Extensive-Stage SCLC Receiving Third-Line Therapy-Data From the German CRISP Registry (AIO-TRK-0315): A Brief ReportMaximilian Rost, Rieke Fischer, Martin Reck, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 24, 2025
Advancing Lung Cancer Staging: Integrating IASLC Recommendations and Bioinformatics to Delineate Tumor OriginsMichael Allgäuer, Klaus Kluck, Petros Christopoulos, et al.Cancers|September 24, 2020
Mass Spectrometry Imaging for Reliable and Fast Classification of Non-Small Cell Lung Cancer SubtypesMark Kriegsmann, Christiane Zgorzelski, Rita Casadonte, et al.Frontiers in Oncology|November 17, 2022
Serum cytokines predict efficacy and toxicity, but are not useful for disease monitoring in lung cancer treated with PD-(L)1 inhibitorsHannah Schindler, Fabienne Lusky, Lea Daniello, et al.Therapeutic Advances in Medical Oncology|August 19, 2021
Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancerNikolaus Magios, Farastuk Bozorgmehr, Anna-Lena Volckmar, et al.Cancer Discovery|January 12, 2026
PD1 blockade-induced DKK1 expression by CD8+ T cells promotes blood-brain barrier permeabilizationAbhilash Deo, Sapir Levin, Chen Buxbaum, et al.Journal of Pharmacological Sciences|February 21, 2014
Intravenous paracetamol as an antipyretic and analgesic medication: the significance of drug metabolismEvangelos J Giamarellos-Bourboulis, Aikaterini Spyridaki, Athina Savva, et al.Frontiers in Oncology|January 30, 2023
High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodesTanja Eichkorn, Jonathan W Lischalk, Cedric Stüwe, et al.Pageof 18